Therapeutic IL2 Treatment in Bacterial Infection
Corresponding Organization :
Other organizations : University of Gothenburg, Guiyang Medical University, Pitié-Salpêtrière Hospital, Sorbonne Université, Assistance Publique – Hôpitaux de Paris
Variable analysis
- RhIL2 treatment
- Survival/mortality of C57BL/6 mice
- Mouse strain (C57BL/6)
- Time of experiment (day 0 to day 10)
- Injection volume (100 μl of PBS)
- Positive control: C57BL/6 mice treated with 25,000 IU/day/mouse of rhIL2 in PBS
- Negative control: C57BL/6 mice injected with PBS
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!